Topmost key players of Halitosis treatment market are Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca, Listerine

Halitosis or bad breath is an offensive, unpleasant smell of the breath, independent of the cause. It can be caused by a variety of things, including diet, medication, poor oral hygiene, and diseases or conditions such as diabetes, GERD, lactose intolerance, gum disease, and more. The most commonly used anti-halitosis products are chewing gum, candies, and mouth rinse. However, it is known that these products only have a masking effect, and thus they are not able to influence the cause of bad breath. The global halitosis treatment market is estimated and forecasted in terms of revenue (USD million) generated by the global market.

Get The Free Sample: https://axiommrc.com/request-for-sample/?report=hc1823

The global halitosis treatment market has gained sustainable growth owing to rising geriatric population and increasing prevalence of chronic diseases. The market is further boosted by rising prevalence of periodontal diseases. Moreover, the market is expected to show robust growth during the forecast period due to surging initiatives by various government agencies and technological advancements. However, the global halitosis treatment market is hindered by lack of awareness about halitosis and its treatment.

Halitosis Treatment Market by Indication

Based on indication, the global halitosis treatment market is segmented into gastrointestinal disorders, kidney disorder, liver disorders, respiratory disorders and systemic disorders. The respiratory segment is further segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. The liver segment is sub-segmented into liver failure, gall bladder diseases, and others. Moreover, the gastrointestinal segment is sub-segmented into oesophageal reflux, stomach cancer, malabsorption, and pharyngitis.

Halitosis Treatment Market by Diagnosis

Based on diagnosis, the market is segmented into b- galactosidase activity assay, BANA test, gas chromatography, halimeter and other tests. The halimeter has become the premier instrument for chronic halitosis research, diagnosis, and therapy. The halimeter offers greatly enhanced patient outcomes in the treatment of oral malodor. It is also used to determine the source of the oral malodor, determine its severity, and monitor the progress of treatment.

Browse The Report: https://axiommrc.com/product/hc1823halitosis-treatment-market/

Halitosis Treatment Market by Drug Treatment

Based on drug treatment, the global halitosis treatment market is categorized into antacids, antiseptics, ranitidine and other treatments (cetylpyridinium chloride and cimetidine). Among these, the antiseptics segment is anticipated to grow at the highest CAGR during the forecast period.

Halitosis Treatment Market Key Players

Some of the key participants in the global halitosis treatment market are Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca, Listerine etc. Most of the prominent companies are aiming at capturing the considerable market share through new product development and research & development at global level.

About Us:
Axiom Market Research & Consulting™ (also known as Axiom MRC), is a full-service market research and data analytics firm, driven by a simple aim of providing key market intelligence to companies to assist them in taking informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Contact Us
Manish Shelar
616 Corporate Way, Suite 2-4268
Valley Cottage, NY 10989
Telephone: +1 (845) 875-9786
Email: sales@axiommrc.com

This release was published on openPR.